A Universal Boronate‐Affinity Crosslinking‐Amplified Dynamic Light Scattering Immunoassay for Point‐of‐Care Glycoprotein Detection

Abstract Herein, we report a universal boronate‐affinity crosslinking‐amplified dynamic light scattering (DLS) immunoassay for point‐of‐care (POC) glycoprotein detection in complex samples. This enhanced DLS immunoassay consists of two elements, i.e., antibody‐coated magnetic nanoparticles (MNP@mAb) for target capture and DLS signal transduction, and phenylboronic acid‐based boronate‐affinity materials as crosslinking amplifiers. Upon the addition of targets, glycoproteins are first captured by MNP@mAb and amplified by target‐induced crosslinking stemming from the selective binding between the boronic acid ligand and cis ‐diol‐containing glycoprotein, thereby resulting in a remarkably increased DLS signal in the average nanoparticle size. Benefiting from the multivalent binding and fast boronate‐affinity reaction between glycoproteins and crosslinkers, the proposed immunosensing strategy has achieved the ultrasensitive and rapid quantitative assay of glycoproteins at the fM level within 15 min. Overall, this work provides a promising and versatile design strategy for extending the DLS technique to detect glycoproteins even in the field or at POC.